Comparison of 6% Hydroxyethyl Starch 130/0.4 With 5% Albumin as Priming Solution for Cardiopulmonary Bypass

Not Applicable

Completed

• Conditions: Mitral Valvular Heart Disease
• Interventions: Drug: 6% hydroxyethyl starch 130/0.4 and 5% albumin

• Registration Number: NCT00978588
• Lead Sponsor: Yonsei University

Brief Summary

Comparison of 6% hydroxyethyl starch 130/0.4 with 5% albumin as priming solution for cardiopulmonary bypass

Detailed Description

Not available

Study Timeline

• Study Start: 2008-02
• Primary Completion: 2008-12
• Study Completion: 2009-08
• Study First Submitted: 2009-09-16
• Study First Submitted QC: 2009-09-16
• Study First Posted: 2009-09-17
• Status Verified: 2012-02
• Last Update Submitted: 2012-02-02
• Last Update Posted: 2012-02-03

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 36

Inclusion Criteria

• Mitral valvular heart disease

Exclusion Criteria

• Status of Infection
• Re-operation
• Liver failure
• Renal disease
• Administration of steroid

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
HES 130/0.4	6% hydroxyethyl starch 130/0.4 and 5% albumin	-
5% albumin	6% hydroxyethyl starch 130/0.4 and 5% albumin	-

Primary Outcome Measures

Name	Time	Method
the pure effect of priming solutions	after CPB